M&A

Abbott extends Alere tender offer
Mass Device
Mon, 08/14/17 - 10:34 am
Abbott Labs
Alere
devices
M&A
Intas Pharmaceuticals offered $1.5bn for 3 divisions of Teva’s in Europe
GoInPharma
Mon, 08/14/17 - 10:04 am
Intas
India
M&A
Teva Pharmaceutical
Europe
Women's Health
oncology
pain management
Why Has 2017 Been a Horrible Year So Far for Biotech Acquisitions?
Motley Fool
Mon, 08/14/17 - 10:03 am
biotech
M&A
JNJ
Actelion
Takeda
Ariad Pharmaceuticals
Gilead Sciences
Pfizer
Amgen
Could a Trump-mandated cash repatriation spur pharma M&A, or just share buybacks?
Fierce Pharma
Sat, 08/12/17 - 12:09 pm
M&A
Donald Trump
tax reform
Teva sells as many as 4 assets: Medis, respiratory, women’s health and oncology
GoInPharma
Fri, 08/11/17 - 11:42 am
Teva Pharmaceutical
M&A
Respiratory
Women's Health
oncology
Medis
Teva’s alarming financial situation makes it vulnerable to takeover attempts by PEs and investment funds
GoInPharma
Thu, 08/10/17 - 11:59 am
Teva Pharmaceutical
M&A
Analyst: Johnson & Johnson tables cardiology M&A – for now
Mass Device
Thu, 08/10/17 - 11:55 am
JNJ
M&A
cardiology
devices
Bard shareholders approve $24B merger with BD
Mass Device
Wed, 08/9/17 - 09:36 am
CR Bard
Becton Dickinson
M&A
devices
Pfizer spinoff Zoetis ups 2017 guidance, eyes more M&A for future growth
Fierce Pharma
Tue, 08/8/17 - 11:19 pm
Zoetis
animal health
M&A
Activist investor pushing for Acorda sale
BioPharma Dive
Tue, 08/8/17 - 11:17 pm
Acorda
investors
M&A
NxStage Medical Acquired by Fresenius for $2 Billion
TheStreet.com
Mon, 08/7/17 - 09:56 pm
Fresenius
NxStage Medical
M&A
dialysis
devices
J&J Vision to acquire TearScience
Mass Device
Mon, 08/7/17 - 11:28 am
JNJ
TearScience
M&A
eye health
ophthalmology
Mallinckrodt bags late-stage infantile jaundice drug in $425M InfaCare buyout deal
Endpoints
Mon, 08/7/17 - 11:25 am
Mallinckrodt
infantile jaundice
InfaCare
M&A
Stanate
Pfizer's Poor Earnings Feed the Allergan Tie-Up Fire
TheStreet.com
Sun, 08/6/17 - 09:50 pm
Pfizer
earnings
Allergan
M&A
Teva, Mylan Seen to Stay on M&A Sidelines
TheStreet.com
Sat, 08/5/17 - 10:08 pm
Teva Pharmaceutical
Mylan Labs
M&A
Johnson & Johnson's 3 Biggest Sources of Growth Over the Next 10 Years
Motley Fool
Sat, 08/5/17 - 09:43 am
JNJ
devices
baby boomers
specialty medicines
M&A
Genmab
Imbruvica
Gilead Could Be Making An Acquisition — But It's Not What You Think
Investors Business Daily
Fri, 08/4/17 - 11:56 am
Gilead Sciences
M&A
United Therapeutics
GSK
Novartis
Jazz nabs early FDA nod for AML med Vyxeos. Is diversifying M&A next?
Fierce Pharma
Thu, 08/3/17 - 09:49 pm
Jazz Pharmaceuticals
FDA
AML
Vyxeos
M&A
Bristol-Myers beefs up big cancer drug pipeline, buying IFM drugs in $2.3B-plus deal
Endpoints
Thu, 08/3/17 - 06:22 pm
Bristol-Myers Squibb
IFM Therapeutics
oncology
M&A
Shire increasingly vulnerable to takeover attempts by big pharma companies
GoInPharma
Wed, 08/2/17 - 09:22 am
Shire
M&A

Pages